Laparoscopic sleeve gastrectomy: a retrospective review of 1- and 2-year results.
BACKGROUND
Recently, laparoscopic sleeve gastrectomy (LSG) has been added as a surgical treatment for obesity. We report our 1- and 2-year results with LSG.


METHODS
From September 2005, we have performed 247 LSGs. We retrospectively reviewed our 1- and 2-year data to assess weight loss, body mass index (BMI), percentage excess weight loss (%EWL), length of stay (LOS), complications, and resolution of diabetes.


RESULTS
A total of 40 patients were eligible for follow-up at 2 years, and 157 patients were eligible for follow-up at 1 year. Data was available on 33/40 patients for 2 years and 131/157 patients for 1 year. Initial mean age, mean weight, and mean BMI for 1-year data were 43.2 years, 270.8 lb, and 44.3 kg/m(2), respectively. Initial mean age, mean weight, and mean BMI for 2-year data were 41.4 years, 273.3 lb, and 45.1 kg/m(2), respectively. Mean weight loss, BMI, and %EWL, for patients at 1 year and 2 years were 89.3 lb, 29.6 kg/m(2), and 78% and 87.5 lb, 30.0 kg/m(2), and 75%, respectively. There was no significant difference between use of 46-Fr, 40-Fr, and 36-Fr bougie with respect to weight loss, BMI or %EWL. Likewise, there was no difference seen between use of 7-cm versus 4-cm antral pouch. Mean LOS for both groups was 1.1 days. A total of 12 complications occurred, including one (0.6%) death and two (1.3%) leaks. A total of 39 patients were diabetic, of whom 32 (82%) were cured of diabetes and the remaining 7 patients had their medications decreased.


CONCLUSIONS
Our results show that LSG is a safe and effective weight-loss procedure with results similar to those of gastric bypass. Additional long-term studies are still needed to accurately compare laparoscopic sleeve gastrectomy with gastric bypass and/or gastric banding.
Jacobs
Moisés
M
Department of Surgery, Jackson Memorial Hospital, Miami, FL, USA.
Bisland
William
W
Gomez
Eddie
E
Plasencia
Gustavo
G
Mederos
Raul
R
Celaya
Carlos
C
Fogel
Roberto
R
D000328:Adult; D015992:Body Mass Index; D003924:Diabetes Mellitus, Type 2 / Q000601:surgery; D005260:Female; D005743:Gastrectomy / Q000295:instrumentation / Q000379:methods*; D006801:Humans; D010535:Laparoscopy / Q000379:methods*; D007902:Length of Stay / Q000706:statistics & numerical data; D008297:Male; D008875:Middle Aged; D009767:Obesity, Morbid / Q000601:surgery*; D011183:Postoperative Complications / Q000453:epidemiology; D012189:Retrospective Studies; D016896:Treatment Outcome; D015431:Weight Loss
JAMA. 1999 Oct 27;282(16):1530-8
10546692
Obes Surg. 2005 May;15(5):612-7
15946449
Surg Endosc. 2006 Jun;20(6):859-63
16738970
JSLS. 2006 Jan-Mar;10(1):86-9
16709367
JAMA. 2002 Oct 9;288(14):1723-7
12365955
Obes Surg. 2006 Nov;16(11):1450-6
17132410
Obes Surg. 2007 Oct;17(10):1297-305
18098398
Obes Surg. 2007 Aug;17(8):1069-74
17953241
Surg Obes Relat Dis. 2007 Jan-Feb;3(1):73-7; discussion 77
17196439
JAMA. 2005 Oct 19;294(15):1909-17
16234497
Obes Surg. 2006 Nov;16(11):1445-9
17132409
JAMA. 2004 Oct 13;292(14):1724-37
15479938
Sci Aging Knowledge Environ. 2004 Jun 16;2004(24):re4
15201431
JAMA. 2003 Jan 8;289(2):187-93
12517229
Surg Obes Relat Dis. 2007 Sep-Oct;3(5):496-502; discussion 502
17903768
Obes Surg. 2003 Dec;13(6):861-4
14738671
N Engl J Med. 2007 Aug 23;357(8):753-61
17715409
Ann Surg. 2003 Jun;237(6):751-6; discussion 757-8
12796570
Obes Surg. 2007 Nov;17(11):1442-50
18219770
Obes Surg. 2007 May;17(5):601-7
17658018
Ann Surg. 1995 Sep;222(3):339-50; discussion 350-2
7677463
N Engl J Med. 2004 Dec 23;351(26):2683-93
15616203
Nutrition. 1996 Oct;12(10):672-6
8936489
Obes Surg. 2005 Nov-Dec;15(10):1469-75
16354529
JAMA. 1999 Oct 27;282(16):1523-9
10546691
Ann Intern Med. 2005 Apr 5;142(7):547-59
15809466
Obes Surg. 2007 Jul;17(7):866-72
17894143
Arch Intern Med. 2000 Apr 10;160(7):898-904
10761953
Obes Res. 1998 Sep;6 Suppl 2:51S-209S
9813653
Surg Endosc. 2007 Oct;21(10):1810-6
17356932
Endoscopy. 2007 Jul;39(7):625-30
17611917
Obes Surg. 2006 Sep;16(9):1138-44
16989696
Obes Surg. 2006 Oct;16(10):1323-6
17059741